Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 28 May 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Repeat biopsy after celiac disease diagnosis does not affect long-term outcomes

Performing routine follow-up biopsy 1 year after diagnosis does not affect long-term outcomes in celiac disease, reports June's issue of the Alimentary Pharmacology & Therapeutics.

News image

A repeat biopsy is recommended, but often omitted in coeliac disease patients on a gluten-free diet. 

The effect of performing or not performing repeat biopsies is currently unknown.

Dr Kurppa and colleagues from Finland identified factors associated with, and the significance of lacking biopsy for long-term outcome. 

Predictors and the importance of incomplete histological recovery after 1 year was investigated in re-biopsied patients.

A total of 760 patients participated in a nationwide follow-up study. 

The research team collected medical data via interviews and patient records, and blood samples were drawn for serology. 

Incomplete mucosal recovery was predicted by more advanced histological disease at diagnosis
Alimentary Pharmacology & Therapeutics
Current symptoms and well-being were assessed by validated PGWB, SF-36 and GSRS questionnaires.

The researchers found that malabsorption was more common among those with a repeat biopsy than those without repeat biopsy.

The team also found that severe symptoms at diagnosis, and concomitant gastrointestinal or musculoskeletal diseases such as arthritis, osteoporosis and back pain were more common among those with a repeat biopsy. 

The team observed that repeat biopsy was more rare in subjects diagnosed in private care or by screening. 

The groups were comparable as to current symptoms and dietary adherence, but those without re-biopsy were less confident of their diet, and more often seropositive on diet. 

The team reported better SF-36 physical functioning, and less pain and indigestion, and total GSRS score. 

The research team found that incomplete mucosal recovery was predicted by more advanced histological and serological disease at diagnosis, whereas the groups did not differ in long-term adherence, symptoms, seropositivity, questionnaire scores, frequency of fractures or malignancies.

Dr Kurppa's team concludes, "Severe disease at diagnosis predicted the record of a repeat biopsy and incomplete mucosal recovery."

"Neither lacking biopsy nor incomplete recovery in a relative short time span of 1 year was associated with poorer long-term outcome, although survival bias cannot be excluded."

Aliment Pharmacol Ther 2017: 45(11): 14591468
19 May 2017

Go to top of page Email this page Email this page to a colleague

 26 May 2017 
Risk of lower GI bleeds with aspirin
 26 May 2017 
Adverse events after outpatient colonoscopy in high-risk patients
 26 May 2017 
Accreditation program for rectal cancer
 25 May 2017 
Poorer male outomes and pediatric IBD
 25 May 2017 
Drug-induced liver injury
 25 May 2017 
Genetics of familial colorectal cancer 
 24 May 2017 
Precision oncology in liver cancer
 24 May 2017 
NAFLD and cardiovascular disease
 24 May 2017 
Accreditation Program for Rectal Cancer
 23 May 2017 
Mother-to-child transmission of hepatitis B virus
 23 May 2017 
Physician burnout and well-being
 23 May 2017 
Genes and pancreatic cancer
 22 May 2017 
Fungal microbiota in IBD
 22 May 2017 
Disease extension in ulcerative colitis
 22 May 2017 
Exercise in dieting obese older adults
 19 May 2017 
Clinical improvement in mild acute pancreatitis
 19 May 2017 
Repeat biopsy and celiac disease outcomes 
 19 May 2017 
Global prevalence of IBS in adults
 18 May 2017 
Genetics and the gut microbiota and metabolic syndrome
 18 May 2017 
Antireflux surgery in extraesophageal reflux
 18 May 2017 
Breath testing in gastrointestinal disorders
 17 May 2017 
ERCP-related radiation cataractogenesis
 17 May 2017 
Satisfactory completion rates in upper GI endoscopy
 17 May 2017 
Tools for assessing dysphagia in eosinophilic esophagitis
 16 May 2017 
UK guideline on GI pediatric to adult transition
 16 May 2017 
Testosterone levels in pre-menopausal women in NAFLD 
 16 May 2017 
Most appropriate delivery mode in women with IBD 
 15 May 2017 
Biopsy after diagnosis in celiac disease
 15 May 2017 
Age and NAFLD diagnosis
 15 May 2017 
GI symptoms in pediatric IBD
 12 May 2017 
Treatment of HCV in liver transplant
 12 May 2017 
Non-vitamin K antagonist oral anticoagulants and GI bleeds
 12 May 2017 
Outcomes after continent ileostomy in Crohn's
 11 May 2017 
Biochemical test for bile acid diarrhea
 11 May 2017 
Biopsy and celiac disease diagnosis
 11 May 2017 
Age and diagnosis of advanced NAFLD fibrosis
 10 May 2017 
Biomarkers for gastric cancer risk assessment
 10 May 2017 
Inflammatory response biomarkers in decompensated cirrhosis
 10 May 2017 
Therapy for NASH
 09 May 2017 
Predicting post-operative Crohn's recurrence
 09 May 2017 
Multidisciplinary approach to pancreas cancer
 09 May 2017 
Hepatic manifestations of IBD
 08 May 2017 
Risk factor for non-obese NAFLD
 08 May 2017 
Central neuromodulators for functional GI Disorders
 08 May 2017 
Chronic liver diseases in the USA
 05 May 2017 
H. pylori infection and preeclampsia
 05 May 2017 
Low-cost oral rotavirus vaccine
 05 May 2017 
 Clostridium difficile and colectomy risk in IBD
 04 May 2017 
Mushroom poisoning and hepatitis
 04 May 2017 
Lean and obese patients with NAFLD
 04 May 2017 
Weight and mortality
 03 May 2017 
Quality and quantity of life in end-stage liver disease
 03 May 2017 
Metabolomes in NASH
 03 May 2017 
Oral direct-acting antivirals for HCV
 02 May 2017 
Transition readiness scores in adolescents with IBD
 02 May 2017 
Hepatocellular carcinoma risk in different etiologies of cirrhosis
 02 May 2017 
IBD disability index
 01 May 2017 
Hepatocellular carcinoma after HCV eradication
 01 May 2017 
Pregnancy and anti-TNF agents in IBD
 01 May 2017 
Functional abdominal pain predicts in children

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us